Authors:
Fukuhara, M
Neves, LA
Li, P
Diz, DI
Ferrario, CM
Brosnihan, KB
Citation: M. Fukuhara et al., The angiotensin II AT(1) receptor antagonist irbesartan prevents thromboxane A(2)-induced vasoconstriction in the rat hind-limb vascular bed in vivo, J HYPERTENS, 19(3), 2001, pp. 561-566
Authors:
Herrington, DM
Brosnihan, KB
Pusser, BE
Seely, EW
Ridker, PM
Rifai, N
MacLean, DB
Citation: Dm. Herrington et al., Differential effects of E and droloxifene on C-reactive protein and other markers of inflammation in healthy postmenopausal women, J CLIN END, 86(9), 2001, pp. 4216-4222
Authors:
Herrington, DM
Pusser, BE
Riley, WA
Thuren, TY
Brosnihan, KB
Brinton, EA
MacLean, DB
Citation: Dm. Herrington et al., Cardiovascular effects of droloxifene, a new selective estrogen receptor modulator, in healthy postmenopausal women, ART THROM V, 20(6), 2000, pp. 1606-1612
Authors:
Herrington, DM
Reboussin, DM
Brosnihan, KB
Sharp, PC
Shumaker, SA
Snyder, TE
Furberg, CD
Kowalchuk, GJ
Stuckey, TD
Rogers, WJ
Givens, DH
Waters, D
Citation: Dm. Herrington et al., Effects of estrogen replacement on the progression of coronary-artery atherosclerosis, N ENG J MED, 343(8), 2000, pp. 522-529
Authors:
Li, P
Fukuhara, M
Diz, DI
Ferrario, CM
Brosnihan, KB
Citation: P. Li et al., Novel angiotensin II AT(1) receptor antagonist irbesartan prevents thromboxane A(2)-Induced vasoconstriction in canine coronary arteries and human platelet aggregation, J PHARM EXP, 292(1), 2000, pp. 238-246
Citation: Kb. Brosnihan, Effect of the angiotensin-(1-7) peptide on nitric oxide release - Questions and answers, AM J CARD, 82(10A), 1998, pp. 19S-19S